HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark D Bednarski Selected Research

Mark D Bednarski Research Topics

Disease

10Neoplasms (Cancer)
11/2010 - 01/2002
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2007 - 10/2003
1Head and Neck Neoplasms (Head and Neck Cancer)
09/2007
1Necrosis
09/2007
1Carcinoma (Carcinomatosis)
09/2004
1Glioblastoma (Glioblastoma Multiforme)
11/2003
1Ischemia
01/2002
1Inflammation (Inflammations)
01/2002

Drug/Important Bio-Agent (IBA)

2OligonucleotidesIBA
09/2007 - 10/2003
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
09/2007 - 03/2004
2Contrast MediaIBA
09/2004 - 08/2003
2GadoliniumIBA
09/2004 - 11/2003
1Histones (Histone)IBA
11/2010
1fluorocarbon 77 (Fluorinert)IBA
11/2010
1dichlorodifluoromethane (FC 12)IBA
11/2010
1ApolipoproteinsIBA
11/2010
1LuciferasesIBA
05/2009
1SteamIBA
05/2009
1Biological ProductsIBA
09/2007
1deoxyuridine triphosphateIBA
09/2007
1Dextrans (Dextran)FDA Link
02/2005
1Pharmaceutical PreparationsIBA
02/2005
1liposomal doxorubicin (Doxil)FDA Link
02/2005
1SuspensionsIBA
02/2005
1Fluorescein (Funduscein)FDA LinkGeneric
02/2005
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2005
1Platelet Endothelial Cell Adhesion Molecule-1IBA
09/2004
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2004
1Integrin beta3 (GPIIIa)IBA
09/2004
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
09/2004
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
03/2004
1Integrin alphaVbeta3IBA
03/2004
1Proteins (Proteins, Gene)FDA Link
11/2003
1Coloring Agents (Dyes)IBA
10/2003
1Hematoxylin (Haematoxylon)IBA
10/2003
1Eosine Yellowish-(YS) (Eosin)IBA
10/2003

Therapy/Procedure

1Extracorporeal Shockwave Therapy
09/2007
1Injections
02/2005
1Subcutaneous Injections
02/2005
1Radioimmunotherapy
03/2004
1Lasers (Laser)
11/2003
1Therapeutics
01/2002